PMID: 2492787Mar 1, 1989Paper

The polycystic ovary syndrome: pathogenesis and treatment

Annals of Internal Medicine
R Barnes, R L Rosenfield

Abstract

To propose a theory for the pathogenesis of the polycystic ovary syndrome that explains the endocrinologic abnormalities of the syndrome and provides a rational approach to therapy. An English-language literature search using MEDLINE (1975 to 1988) and extensive bibliographic reviews of identified articles. We reviewed the literature and selected 169 articles considered most relevant for the definition of the endocrinologic abnormalities, elucidation of pathogenic mechanisms, or delineation of therapeutic interventions. The authors independently assessed study quality and data concerning endocrinologic abnormalities, pathogenic mechanisms, and therapy of the polycystic ovary syndrome. The polycystic ovary syndrome may be best defined as functional, gonadotropin-dependent ovarian hyperandrogenism. The polycystic ovary syndrome results when a primary defect increases one of three variables: the ratio of the serum concentrations of luteinizing hormone to follicle stimulating hormone, the ratio of the intraovarian concentrations of androgen to estrogen, or follicular atresia. An increase in one of these variables can then induce successive abnormalities in one or more of the remaining two variables in a to-and-fro manner. Evidence ...Continue Reading

Citations

Jan 1, 1995·Lasers in Surgery and Medicine·E M KaaijkF van der Veen
Jan 1, 1995·Journal of Inherited Metabolic Disease·P J Lee, J V Leonard
May 1, 1995·Journal of General Internal Medicine·R E WatsonP C Alguire
Jul 16, 2005·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Lei WangJia-Hao Sha
Aug 1, 1995·International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics·H Meden-Vrtovec
Aug 5, 1999·Steroids·S Thys-JacobsJ P Bilezikian
Apr 18, 2003·Medical Hypotheses·Eugene A Foster
Jun 3, 1999·Endocrinology and Metabolism Clinics of North America·R L Rosenfield
Jul 23, 1998·Journal of Clinical Epidemiology·T PierpointH S Jacobs
Aug 1, 1995·Ceská gynekologie·J Zivný
Feb 1, 1992·Clinical Endocrinology·V ToscanoF Sciarra
Aug 1, 1993·Clinical Endocrinology·Y Sahin, F Keleştimur
Nov 1, 1994·Clinical Endocrinology·D DewaillyP Fossati
May 1, 1994·Clinical Endocrinology·K H PoldermanE A van der Veen
Oct 1, 1995·Clinical Endocrinology·F J RaphaelJ H Lacey
Jun 1, 1994·Diabetic Medicine : a Journal of the British Diabetic Association·C J AdcockD B Dunger
Mar 1, 1994·American Journal of Reproductive Immunology : AJRI·M H GoniG Tolis
Mar 1, 1991·Postgraduate Medical Journal·J M Goldman, L J Kapadia
Mar 1, 1996·Postgraduate Medical Journal·O B GateeI A Salama
Aug 1, 1990·The Journal of Clinical Investigation·J F CaraR L Rosenfield
Dec 18, 1998·Journal of Endocrinological Investigation·V Toscano
Dec 18, 1998·Journal of Endocrinological Investigation·R B Barnes
Apr 1, 1996·Journal of Endocrinological Investigation·B AmbrosiR Ferrario
Mar 9, 2002·Journal of Endocrinological Investigation·T ReB Ambrosi
Jan 24, 1998·Journal of Endocrinological Investigation·A RuizJ E Sánchez-Criado
Mar 1, 1995·Annals of Anatomy = Anatomischer Anzeiger : Official Organ of the Anatomische Gesellschaft·C SchubertH Michna
Jul 4, 2009·Taiwanese Journal of Obstetrics & Gynecology·Batool RashidiFarid Zayerii
Apr 7, 2009·Obstetrics and Gynecology Clinics of North America·Samantha M Pfeifer, Sari Kives
Mar 1, 1992·Obstetrics and Gynecology Clinics of North America·R A Wild
Dec 15, 2004·European Journal of Obstetrics, Gynecology, and Reproductive Biology·Suhail A R DoiKamal A S Al-Shoumer
Jun 1, 1997·Baillière's Clinical Obstetrics and Gynaecology·R L Rosenfield
Jan 11, 2000·Baillière's Clinical Obstetrics and Gynaecology·A Balen
Jun 1, 1992·Baillière's Clinical Obstetrics and Gynaecology·K Gordon, G D Hodgen
Apr 11, 2001·Obstetrics and Gynecology Clinics of North America·J V ZborowskiJ A Cauley
Sep 1, 1994·The American Journal of Medicine·M A CharlesW C Knowler
Apr 1, 1996·American Journal of Obstetrics and Gynecology·D S GuzickS K Wolfson
May 28, 1993·Annals of the New York Academy of Sciences·M I New

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.